Meng X, Wang M, Wang X, Sun G, Ye J, Xu H, Sun X
Key Laboratory of Bioactive Substances and Resources Utilization of Chinese Herbal Medicine, Ministry of Education, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , P. R. China.
Free Radic Res. 2014 Jul;48(7):823-38. doi: 10.3109/10715762.2014.911853. Epub 2014 May 7.
Notoginsenoside R1 (NGR1) is a novel phytoestrogen that is isolated from Panax notoginseng. We have recently found that NGR1 showed neuroprotection in vitro against oxidative stress through estrogen receptor (ER)-dependent activation of Akt/Nrf2 pathways. However, whether NGR1 has neuroprotective effect against cerebral ischemia-reperfusion (I/R) injury in vivo is unknown. In this study, we used in vivo and in vitro models of cerebral I/R injury that demonstrate middle cerebral artery occlusion and reperfusion in rats, as well as oxygen-glucose deprivation followed by reoxygenation (OGD/R) in primary cortical neurons. These models were used to evaluate NGR1 neuroprotection. Three-day pretreatment with NGR1 (20 mg/kg; i.p.) significantly improved neurologic outcomes and reduced cerebral infarct volume. Pretreatment of primary cortical neurons with NGR1 (25 μM) for 24 h prevented apoptosis and oxidative stress induced by OGD/R. NGR1 inhibited apoptosis by inhibiting mitochondrial membrane potential disruption, caspase-3 activation, and DNA fragmentation. NGR1 prevented oxidative stress by suppressing NADPH oxidase- and mitochondrion-derived superoxide and inhibiting production of malondialdehyde, protein carbonyl, and 8-hydroxydeoxyguanosine in vivo and in vitro. NGR1 induced ER-dependent activation of Akt/Nrf2 pathways by increasing ERα, ERβ, phospho-Akt, phospho-GSK3β, nuclear Nrf2, and HO-1 expression in vivo and in vitro. Pretreatment with ICI-182780, LY294002, or Snpp abolished NGR1-mediated neuroprotection against oxidative stress and apoptosis in vitro. In conclusion, NGR1 showed neuroprotection against cerebral I/R injury in vivo and in vitro. The mechanism of NGR1 neuroprotection involves inhibition of NADPH oxidase activity and mitochondrial dysfunction via ER-dependent activation of Akt/Nrf2 pathways.
三七皂苷R1(NGR1)是一种从三七中分离出来的新型植物雌激素。我们最近发现,NGR1在体外通过雌激素受体(ER)依赖性激活Akt/Nrf2途径对氧化应激具有神经保护作用。然而,NGR1在体内对脑缺血再灌注(I/R)损伤是否具有神经保护作用尚不清楚。在本研究中,我们使用了体内和体外脑I/R损伤模型,这些模型分别展示了大鼠大脑中动脉闭塞和再灌注,以及原代皮质神经元中的氧糖剥夺再复氧(OGD/R)。这些模型用于评估NGR1的神经保护作用。用NGR1(20 mg/kg;腹腔注射)进行三天预处理可显著改善神经功能结局并减少脑梗死体积。用NGR1(25 μM)对原代皮质神经元进行24小时预处理可预防OGD/R诱导的细胞凋亡和氧化应激。NGR1通过抑制线粒体膜电位破坏、半胱天冬酶-3激活和DNA片段化来抑制细胞凋亡。NGR1通过在体内和体外抑制NADPH氧化酶和线粒体衍生的超氧化物,并抑制丙二醛、蛋白质羰基和8-羟基脱氧鸟苷的产生来预防氧化应激。NGR1通过在体内和体外增加ERα、ERβ、磷酸化Akt、磷酸化GSK3β、核Nrf2和HO-1的表达来诱导ER依赖性激活Akt/Nrf2途径。用ICI-182780、LY294002或Snpp进行预处理可消除NGR1在体外介导的对氧化应激和细胞凋亡的神经保护作用。总之,NGR1在体内和体外均对脑I/R损伤具有神经保护作用。NGR1神经保护的机制包括通过ER依赖性激活Akt/Nrf2途径抑制NADPH氧化酶活性和线粒体功能障碍。